Cas 1245079-23-5,[(3R,4S)-1-(5-cyanopyrimidin-2-yl)-4-(2,5-difluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester

1245079-23-5

Post Buying Request

Basic information

Product Name: [(3R,4S)-1-(5-cyanopyrimidin-2-yl)-4-(2,5-difluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester
Synonyms: [(3R,4S)-1-(5-cyanopyrimidin-2-yl)-4-(2,5-difluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester
CAS NO:1245079-23-5
Molecular Formula:
Molecular Weight: 401.416
EINECS: N/A
Product Categories: N/A
Mol File: 1245079-23-5.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [(3R,4S)-1-(5-cyanopyrimidin-2-yl)-4-(2,5-difluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: [(3R,4S)-1-(5-cyanopyrimidin-2-yl)-4-(2,5-difluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester(1245079-23-5)
EPA Substance Registry System: [(3R,4S)-1-(5-cyanopyrimidin-2-yl)-4-(2,5-difluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester(1245079-23-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1245079-23-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1245079-23-5 Suppliers

Recommended suppliersmore

1245079-23-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1245079-23-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,0,7 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1245079-23:
(9*1)+(8*2)+(7*4)+(6*5)+(5*0)+(4*7)+(3*9)+(2*2)+(1*3)=145
145 % 10 = 5
So 1245079-23-5 is a valid CAS Registry Number.

1245079-23-5Upstream product

1245079-23-5Downstream Products

1245079-23-5Relevant articles and documents

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

-

Page/Page column 33, (2010/10/03)

The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1245079-23-5